期刊
JOURNAL OF NEUROIMMUNOLOGY
卷 305, 期 -, 页码 16-18出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jneuroim.2016.12.016
关键词
-
Immune checkpoint inhibitors such as Pembrolizumab are used to restore antitumour immune response. It is important to be vigilant of immune mediated adverse events related to such therapy. We report a case of autoimmune limbic encephalitis with Contactin-Associated Protein-like 2 (CASPR2) antibody secondary to Pembrolizumab therapy for metastatic melanoma. (C) 2017 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据